Delic Holdings Corp. · OTC:DELCF
Delic — Investor Presentation (March 2021)
18 slides from Delic's investor presentation, Mar 15, 2021
Slide 1: Expanding always. In all ways.
2021 Expanding always. In a// ways.
Slide 2: Disclaimer
CORP DISCLAIMER You Must Read This Before Continuing This corporate presentation (“Presentation”) is confidential and contains proprietary non-public information regarding Delic Corp (“Delic”, the “Company”, “we”, “us” or “our”). This Presentation is for information purposes only and does not consti
Slide 3: Mission Statement
CORP MISSION STATEMENT Delic Corp is a marketplace for the mainstream to access psychedelic wellness. We create a diverse ecosystem of opportunities by investing in talented entrepreneurs with cutting edge ideas. We lead with 25 years of working knowledge in cannabis, finance, and psychedelic resear
Slide 4: Problems and Solutions
PROBLEMS SOLUTIONS *3 *1 Traditional palliative *6 *8 care methods do not Every successfully treat end 50% Approx. 40 seconds of life (EOL) anxiety. of Americans will 50 million meet the criteria people in the US are someone in the world for a mental health addicted to some commits suicide. conditio
Slide 5: Market Potential
Market Potential ~32M ~17% *9 *10 People in the US Have Used Of All American Adults Between Psychedelics at Least Once the Ages of 21 and 64 $500B $16B $71B *11 *12 *13 + Annual US Spend on Anxiety Disorder & 2016 Spend to Treat Perscription Drugs Depression Treatment Market Depressive Disorders $23
Slide 6: Team
CORP TEAM Our team is comprised of leaders, doers and free thinkers. With confidence rooted in the successes of our collective experiences, we are determined to make consious moves that will be a lasting part of our legacy. OPERATIONS MATT STANG JACKEE STANG MATHEW LEE ZAK GARCIA JOHN COLEMAN CEO/FO
Slide 7: Team: Advisors
CORP TEAM ADVISORS SHEP GORDON GREG CROWE DR. DAVE RABIN BARBARA BRANAMAN ADVISOR M&A ADVISOR ADVISOR ADVISOR CIO DIRECTOR CIO & CO-FOUNDER ED & CO-FOUNDER BOARD MEMBER CEO & FOUNDER EXECUTIVE VP OF VP/GM of HOSTING NY TIMES FILM AGENT & SERENDIPITY GC 14TH ROUND APOLLO BOARD OF MEDICINE SEMPER FI O
Slide 8: Media, Health, Science
Expanding always. In all ways. Media Health Science 8
Slide 9: Media
CORP Media Educating and motivating the masses through a variety of digital platforms. 9
Slide 10: Reality Sandwich
REALITY SANDWICH DIGITAL MAGAZINE WEBSITE • +5000 pieces of free content VIRTUAL EVENTS • 460k website users in 2020 • 1.4M 2020 website pageviews in 2020 • 2k+ LIVE attendees • 551 keywords on 1st page of Google • 3k+ Livestream Playbacks • 77 keywords in top 3 Google rankings • Dozen+ images on pa
Slide 11: The Delic Revolution is Here
CORP The Delic Revolution is Here DELIC has been featured on the following platforms. CORP CORP CORP And so are we. 11
Slide 12: Health
CORP Health Psychedelic treatments have the potential to help billions of people live happier lives.
Slide 13: Experienced Management Team; Clinic Economics
Experienced Management Team Clinic Economics • Over 15 years of experience in the clinic and medical • Cost USD$250,000 to open a clinic space, scaling and operating over 20 clinics • Average clinic takes 6 months to break even • Exclusively administering IV Ketamine infusion allows • Average clinic
Slide 14: Science
CORP Science Advanced extraction and testing facilities are the backbone of the legal market.
Slide 15: Complex Biotech Discovery Ventures
COMPLEX BIOTECH DISCOVERY VENTURES A licensed cannabis and psilocybin research laboratory. Founded by award-winning chemists, CBDV focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. CBDV was granted a Section 56
Slide 16: Locations
CORP LOCATIONS Ketamine Infusion Centers Bakersfield, California Phoenix, Arizona Complex Biotech Discovery Ventures Vancouver, Canada Meet Delic Los Angeles, CA 16
Slide 17: Capital Structure
S CAPITAL STRUCTURE Basic Issued & Outstanding 55,193,450 Options 4,025,000 Warrants 273,000 Fully Diluted 59,491,450 17 17
Slide 18: Contact
CORP CONTACT Daniel Southan-Dwyer (708) 515-4925 invest@deliccorp.com 18